|
|
|
Nearly Half Involved Payment to Generic Firms, Restricted Generics’ Ability to Enter the Market WASHINGTON, May 21, 2008-The Federal Trade Commission’s Bureau of Competition today issued a summary of agreements filed with the agency in fiscal year 2007 (ending September 30, 2007) by generic and...
Full Coverage:
FTC's Bureau of Competition Issues Statement and Report Regarding 2007 Pharmaceutical Settlement...
On May 21, 2008, the Bureau of Competition of the Federal Trade Commission ("FTC") released its Summary of Agreements Filed in FY 2007, A Report by the Bureau of Competition for agreements filed with the FTC under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ("MMA")....
U.S. FTC reports 14 deals to delay generics in '07
By Diane Bartz WASHINGTON, May 23 (Reuters) - Brand name pharmaceutical companies struck 14 deals that led to delayed sale of cheaper generic drugs in the 2007 fiscal year, the U.S. Federal Trade Commission said. The FTC considers the controversial deals a violation of antitrust law but the...
Drug Firms Inflating Prices of Generic Drugs - KDI
A 20-mg tablet of a drug used to treat hyperlipidaemia made by a U.S.-based multinational pharmaceutical company sells for W1,219 in Korea (US$1=W1,044). As many as 87 different generic versions of this drug are available, containing the same active ingredients as the original. Forty such...
Pharmaceutical Pay-to-Delay Deals Hurt Consumers Says FTC
Legal deals between brand-name drug manufacturers and generics firms, called "Pay-to-Delay", are costing consumers, says an annual report released by the US Federal Trade Commission (FTC). Fourteen settlements of this kind were made between pharmaceutical companies in 2007, usually following a...
FTC: Legal Settlements Delay Cheaper Drugs
Pharmaceutical companies eager to keep less expensive alternatives to their drugs off the market are increasingly reaching legal agreements with generic drugmakers to accomplish that goal, a government agency said Wednesday. The FTC says that by jamming the pipeline of cheaper drugs, such...
FTC says 'pay-for-delay' contracts between drug makers hurt consumers
JURIST] Drug companies are harming consumers by using "pay-for-delay" legal agreements to keep cheaper generic prescription drugs off the market, according to a report [PDF text; press release] released Wednesday by the US Federal Trade Commission (FTC) [official website]. The report compares...
FTC: Legal settlements delay cheaper drugs
WASHINGTON – Pharmaceutical companies are using legal settlements with generic drugmakers to delay the introduction of cheaper medicines, a government agency said Wednesday. “Pay-for-delay settlements continue to proliferate,” FTC Commissioner Jon Leibowitz said in a statement. The Pharmaceutical...
Settlements Used to Delay Cheaper Drugs
Pharmaceutical companies are using legal settlements with generic drug makers to delay the introduction of cheaper medicines, a government agency said Wednesday. In a 12-month period that ended last Sept. 30, 14 of 33 agreements to settle patent litigation between brand-name drug companies and...
FTC Derides Pay-To-Delay Deals With Generics
Drugmakers win, consumers lose. That's the message from the Federal Trade Commission, which released its latest annual report on the deals between brand-name and generic drugmakers. In fiscal year 2007, which ended September 30, 2007, there were 33 final settlements. Of those, 14, or 42 percent,...
FTC: Legal settlements delay cheaper drugs
U.S. pharmaceutical companies eager to keep less expensive alternatives to their drugs off the market are increasingly reaching legal agreements with generic drugmakers to accomplish that goal, a government agency said Wednesday. The agency has sued to block some settlements and is supporting...
International editions
English - US | English - UK | Deutsch | Française | Español | Português | Italiano | Česká | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese)Copyright © 2008 Newstin a.s. All rights reserved. 4.2.5,fe-web-4.2.5;commons-4.2.1;api-4.2.1;fe-4.2.3, 10.10.1.27